EUVIMEDEUVIMED entdecken
Open Access

The miR-155-5p/FBXO11 axis inhibits the progression of gastric cancer via the mTOR pathway

Tao Yuan, Haiyan Liu, Fangfang Li, Qingyue Meng, Yajuan Wang, Mei Yuan

Translational Cancer Research · 2025-02 · 14 (2) · 1375-1387

DOI: 10.21037/tcr-2025-8 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Translational Cancer Research, 2025-02. Verfasst von Tao Yuan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Hospital Office, The No. 3 People's Hospital of Qingdao, Qingdao, China. Die Arbeit wurde bisher 3-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Gastric cancer (GC) is a leading cause of cancer-related death. MicroRNAs (miRNAs or miRs) play a crucial role in the pathology of GC, including cell proliferation, invasion, and metastasis. In this study, genes targeted by miR-155-5p were predicted using bioinformatic tools. We found that the expression of miR-155-5p in GC cell lines differed relative to the expression of F-box protein 11 (FBXO11), which is involved in the regulation of cellular processes. This study sought to examine the function of miR-155-5p and the precise mechanism underlying its regulatory function in modulating proliferation and apoptosis in GC.

Methods

The luciferase reporter assay results showed that miR-155-5p bound directly to the three prime untranslated region (3'-UTR) of FBXO11, which further downregulated FBXO11 expression. Quantitative reverse transcription-polymerase chain reaction (qRT-PCR) and Western-blot analyses confirmed that miR-155-5p negatively regulated the messenger RNA (mRNA) and protein expression of FBXO11. The effects of FBXO11 on cell proliferation and apoptosis in GC cell lines was further examined using Cell Counting Kit-8 (CCK-8) and flow cytometry.

Results

We found that FBXO11 promoted proliferation and decreased apoptosis in GC cells. Conversely, rescue experiments showed that the knockdown of FBXO11 limited the effects of miR-155-5p on the proliferation and apoptosis of GC cells, providing further evidence that FBXO11 is a functional target of miR-155-5p. Further, the overexpression of miR-155-5p inhibited cell growth via the targeted inhibition of FBXO11 that regulated mammalian target of rapamycin (mTOR) signaling pathway in the GC cells.

Conclusions

Overall, these results showed that miR-155-5p may serve as a tumor suppressor in GC and that the miR-155-5p/FBXO11 axis regulates tumor progression via the mTOR signaling pathway. Consequently, our findings may lead to the development a novel treatment strategy for GC.

Schlagwörter

Stichwörter der Autor:innen

FBXO11Gastric cancer (GC)mammalian target of rapamycin pathway (mTOR pathway)miR-155-5pproliferation

Autor:innen und Institutionen

  • Hospital Office, The No. 3 People's Hospital of Qingdao, Qingdao, China.
  • Department of Dermatology, The No. 8 People's Hospital of Qingdao, Qingdao, China.
  • Department of Respiratory Medicine, The No. 8 People's Hospital of Qingdao, Qingdao, China.
  • Department of Health Management Center, The No. 8 People's Hospital of Qingdao, Qingdao, China.
  • Department of Gerontology, The No. 8 People's Hospital of Qingdao, Qingdao, China.
  • Health Management Center, the Affiliated Hospital of Qingdao University, Qingdao, China.

Zitieren

APA

Yuan, T., Liu, H., Li, F., Meng, Q., Wang, Y., & Yuan, M. (2025). The miR-155-5p/FBXO11 axis inhibits the progression of gastric cancer via the mTOR pathway. Translational Cancer Research, 14(2), 1375-1387. https://doi.org/10.21037/tcr-2025-8

Vancouver

Yuan T, Liu H, Li F, Meng Q, Wang Y, Yuan M. The miR-155-5p/FBXO11 axis inhibits the progression of gastric cancer via the mTOR pathway. Translational Cancer Research. 2025;14(2):1375-1387. doi:10.21037/tcr-2025-8

BibTeX
@article{Yuan2025,
  author = {Yuan, Tao and Liu, Haiyan and Li, Fangfang and Meng, Qingyue and Wang, Yajuan and Yuan, Mei},
  title = {The miR-155-5p/FBXO11 axis inhibits the progression of gastric cancer via the mTOR pathway},
  journal = {Translational Cancer Research},
  year = {2025},
  volume = {14},
  number = {2},
  pages = {1375--1387},
  doi = {10.21037/tcr-2025-8}
}
Kostenlos starten →